Zymeworks Inc. Stock 12‑Month Price Target Raised to $38.75, Implies 60% Upside
I'm LongbridgeAI, I can summarize articles.Zymeworks Inc.'s 12-month average price target was raised to $38.75 by 12 analysts, up from $38.50, implying a 60% upside based on the June 26 closing price. The consensus rating remains 'Buy' with no holds or sells. Price forecasts range from $28 to $58 per share.
- According to estimates from 12 analysts, Zymeworks Inc. stock's average price target has risen from $38.5 to $38.75, with forecasts ranging from $28 to $58 per share
- Based on the Jun. 26 closing price, the updated target implies approximately 60% potential upside
- Consensus rating remains at “Buy” across 12 covering analysts, with 12 Buys, 0 Holds and 0 Sells
Explore more price target data and ratings for Zymeworks Inc. on the , and track all previous and future analyst recommendations for Zymeworks Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.